Pharma Industry

May 27th 2025

As digital clinics race to capitalize on the GLP-1 weight loss boom, concerns grow over quality, safety and the erosion of patient-centered care.

May 20th 2025

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

May 1st 2025

‘Wild west’ of pharmaceutical sales developed as patients clamor for GLP-1s for obesity treatment.

April 30th 2025

Novavax continues working with FDA, but case could signal a shift in broader vaccine procedures.